Guru Ownership Trend
Guru Analysis for Ocular Therapeutix, Inc. (OCUL)
Ocular Therapeutix, Inc. (OCUL), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q3 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $10.81 M.
Top institutional holders include Cliff Asness and Renaissance Technologies (RenTech).
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $25.7 M net outflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 42.8%. Conversely, Steven Cohen reduced exposure by 91.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q3 2026)
Guru Consensus (Q3 2026)
FAQs for Ocular Therapeutix, Inc. (OCUL)
Major holders include Cliff Asness ($8.56 M), Renaissance Technologies (RenTech) ($4.15 M), Steven Cohen ($2.17 M). According to the latest reported data, 3 tracked investment managers collectively hold approximately 1.94 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $25.7 M, with 2 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited OCUL. The total reported sell value was $28.21 M.
Yes, 0 managers opened new positions in OCUL, and 2 increased their existing holdings. The total reported buy value was $2.51 M.